| 영문 | linear accelerator | 한글 | 선상가속기 |
|---|---|---|---|
| 설명 | 치료방사선과에서 이용하는 기계로서 전자를 생성해 낸다. 전자는 단순히 X-선과는 다른 것으로 전자가 금속에 부딪혀 나오는 것이 X-선이다. 전자는 진단목적보다는 치료목적으로 주로 피부의 악성종양(암)에 사용된다. |
||
| 영문 | prothrombin time | 한글 | 프로트롬빈시간 |
|---|---|---|---|
| 설명 | 프로트롬빈은 간에서 합성되는 비타민 K 의존성 응고단백질의 하나이며, 프로트롬빈시간은 외인계 응고활성을 종합적으로 특정하는 검사의 하나이다. 피검혈장에 칼슘이온과 조직트롬보플라스틴(제III 응고인자)을 가해, 섬유소가 나타날 때까지의 시간으 측정한다. |
||
| 영문 | conversion | 한글 | 전환 |
|---|---|---|---|
| 설명 | 1. 내부의 갈등에 대한 무의식적 방어메커니즘으로 내부의 갈등을 특정한 신체의 증상으로 변환하여 나타내는 것. 2. 어떤 병이나 반응이 한 상태에서 다른 상태로 변하는 것. |
||
| 영문 | conversion disorder | 한글 | 전환장애 |
|---|---|---|---|
| 설명 | 내부의 갈등에 대한 무의식적 방어메커니즘으로 내부의 갈등을 특정한 신체의 증상으로 변환하여 나타내는 것을 말 한다. 이 전환으로 인한 증상을 주로 나타내는 정신질환을 전환장애라고 한다. 전환으로 인한 증상으로 대표적인 것으로는 마비, 경련, 의식장애 등이다. 대개 그 병을 일으킬 만한 병변이 존재하지 않고, 심리적 갈등이 심할 경우에 더욱 증상이 심해지고 증상의 발현으로 인해서 내부적 갈등이 감소되고 증상의 발현으로 인한 2차적 이득(가족들의 관심집중, 돌봐줌)이 있는 것이 이 전환장애의 특징이다. 대개 이 전환장애 환자는 자신의 질환에 대해서 특징적으로 매우 무관심한 태도를 취한다. |
||
| 영문 | serum | 한글 | 혈청 |
|---|---|---|---|
| 설명 | 혈액의 성분 중 고형성분인 혈구세포(적혈구, 백혈구 등), 혈소판을 제외한 부분을 혈장이라고 하고, 혈장에서 섬유소를 제외한 부분을 혈청이라고 한다. |
||
| PPCA | plasma prothrombin conversion accelerator; proserum prothrombin conversion accelerator |
|---|---|
| SPCA | serum prothrombin conversion accelerator; Society for Prevention of Cruelty to Animals |
| APP | acute phase protein; alum-precipitated pyridine; aminopyrazolopyrimidine; amyloid peptide precursor;... |
| ECP | ectrodactyly-cleft palate [syndrome]; effector cell precursor; endocardial potential; eosinophil cat... |
| PCF | peripheral circulatory failure; pharyngoconjunctival fever; platelet complement fixation; posterior ... |
| AMS | Accelerator Mass Spectrometry |
|---|---|
| LINAC | Linear Accelerator |
| (14)C | Conversion of |
| 1-14C | Conversion of |
| 4-14C | Conversion of |
| serum prothrombin conversion accelerator | <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa. Chemical name: Blood-coagulation factor VII (12 Dec 1998) |
|---|---|
| proserum prothrombin conversion accelerator | A coagulation (clotting) factor. Classic haemophilia (haemophilia A) is due to a congenital deficiency in the amount (or activity) of factor VIII. Factor VIII is also known as antihemophiliac factor (AHF) or antihemophiliac globulin (AHG). The gene for factor VIII (that for classic haemophilia) is on the X chromosome so females can be silent carriers without symptoms and males can be haemophiliacs. (12 Dec 1998) |
| prothrombin accelerator | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| serum accelerator | <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa. Chemical name: Blood-coagulation factor VII (12 Dec 1998) |
| serum accelerator globulin | A substance in serum that accelerates the conversion of prothrombin to thrombin in the presence of thromboplastin and calcium; produced by the action of traces of thrombin upon plasma accelerator globulin. (05 Mar 2000) |
| Amine Precursor Uptake and Decarboxylation | <pharmacology, physiology> Paracrine cells of which argentaffin cells are an example. Usage of the term APUD is neither helpful nor memorable. Acronym: APUD (11 Nov 1997) |
| amyloid beta-protein precursor | A precursor to the amyloid-beta protein (beta/a4). Alterations in the expression of the amyloid beta-protein precursor (abpp) gene, located on chromosome 21, plays a role in the development of the neuropathology common to both alzheimer disease and down syndrome. Abpp is associated with the extensive extracellular matrix secreted by neuronal cells. Upon cleavage, this precursor produces three proteins of varying amino acid lengths: 695, 751, and 770. The beta/a4 (695 amino acids) or beta-amyloid protein is the principal component of the extracellular amyloid in senile plaques found in alzheimer disease, down syndrome and, to a limited extent, in normal aging. (12 Dec 1998) |
| amyloid precursor protein | <protein> Individuals with Alzheimer's disease are characterised by extensive accumulation of amyloid in the brain, referred to as senile plaques. These consist of a core of amyloid fibrils surrounded by dystrophic neurites. The principal component of the amyloid fibrils is B/A4, a peptide derived from the larger APP. The specific role of amyloid protein is unclear but it is thought that amyloid deposits may cause neurons to degenerate. Amyloid deposits also occur in brains of older Down's Syndrome patients. (04 May 1997) |
| angiotensin precursor | angiotensin |
| precursor | Something that precedes. 1. <biochemistry> In biological processes, a substance from which another, usually more active or mature substance is formed. 2. In clinical medicine, a sign or symptom that heralds another. Origin: L. Praecursor = a forerunner (18 Nov 1997) |
| enzyme precursor | <biochemistry> Inactive precursors that can be converted to active enzymes. Enzyme precursors containing extra-long polypeptide chains that block activity are activated by acid or enzymatic hydrolysis to remove the inhibiting portion. (12 Dec 1998) |
| prothrombin | Clotting Factor II. Origin: Gr. Thrombos = cloth in (18 Nov 1997) |
| prothrombin and proconvertin test | A test formerly used by some to control anticoagulant therapy with bishydroxycoumarin and indandione drugs. Synonym: P and P test. (05 Mar 2000) |
| prothrombin deficiency | A congenital or acquired disorder of blood clotting where there is a deficiency of factor II (prothrombin), one of 20 necessary plasma proteins for normal blood coagulation. Acquired factor II deficiency may result from vitamin K deficiency, severe liver disease and anticoagulant drugs. Symptoms include abnormal bleeding, nosebleeds, abnormal menstrual bleeding, easy bruising and umbilical cord bleeding at birth. Treatment involves the infusion of fresh frozen plasma. Vitamin K may be administered in select cases. (27 Sep 1997) |
| prothrombin test | A quantitative test for prothrombin in the blood based on the clotting time of oxalated blood plasma in the presence of thromboplastin and calcium chloride; measures the integrity of the extrinsic and common pathways of coagulation. See: prothrombin time. Synonym: Quick's method, Quick's test. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|